11beta,12beta-epoxyfriedours-14-en-3-alpha-ol - Compound Card

11beta,12beta-epoxyfriedours-14-en-3-alpha-ol

Select a section from the left sidebar

11beta,12beta-epoxyfriedours-14-en-3-alpha-ol

Structure
Zoomed Structure
  • Family: Plantae - Tiliaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Triterpene
Canonical Smiles C[C@H]1CC[C@@]2(C([C@@H]1C)[C@@]1(C)[C@@H]3O[C@@H]3C3[C@](C1=CC2)(C)CC[C@H]1[C@@]3(C)CC[C@H](C1(C)C)O)C
InChI InChI=1S/C30H48O2/c1-17-9-13-27(5)14-10-20-29(7)15-11-19-26(3,4)21(31)12-16-28(19,6)24(29)22-25(32-22)30(20,8)23(27)18(17)2/h10,17-19,21-25,31H,9,11-16H2,1-8H3/t17-,18+,19+,21+,22+,23?,24?,25+,27-,28+,29+,30-/m0/s1
InChIKey GOHBPXGGNXNYEV-LEBQWQGOSA-N
Formula C30H48O2
HBA 2
HBD 1
MW 440.71
Rotatable Bonds 0
TPSA 32.76
LogP 7.01
Number Rings 6
Number Aromatic Rings 0
Heavy Atom Count 32
Formal Charge 0
Fraction CSP3 0.93
Exact Mass 440.37
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Duboscia macrocarpa Tiliaceae Plantae 3105915

Showing of synonyms

  • Kamdem RST, Wafo P, et al. (2018). Bioactive chemical constituents of Duboscia macrocarpa Bocq., and X-ray diffraction study of 11β, 12β-epoxyfriedours-14-en-3α-ol.. Fitoterapia,2018, 125, 65-71. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCCC2C1CCC(C2C(O3)C34)C=5C4C6C(CC5)CCCC6

Level: 0

Mol. Weight: 440.71 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.13
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.41
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.69

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.81
Plasma Protein Binding
67.03
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
17.09
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
1.6
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
1.3
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
6.12
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Toxic
T. Pyriformis
-117.66
Rat (Acute)
1.67
Rat (Chronic Oral)
0.99
Fathead Minnow
3.87
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Toxic
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
426.46
Hydration Free Energy
-2.55
Log(D) at pH=7.4
7.12
Log(P)
7.49
Log S
-6.73
Log(Vapor Pressure)
-7.36
Melting Point
190.42
pKa Acid
9.44
pKa Basic
7.35
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Abscisic acid receptor PYL3 Q9SSM7 PYL3_ARATH Arabidopsis thaliana 3 0.7695
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 2 0.7254

Download SDF